1,853 Shares in Chemed Corporation $CHE Bought by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Chemed Corporation (NYSE:CHE) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,853 shares of the company’s stock, valued at approximately $936,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CHE. Vise Technologies Inc. lifted its position in shares of Chemed by 45.9% in the third quarter. Vise Technologies Inc. now owns 2,022 shares of the company’s stock worth $1,021,000 after purchasing an additional 636 shares in the last quarter. North Dakota State Investment Board acquired a new position in Chemed during the third quarter worth $201,000. VestGen Advisors LLC bought a new position in Chemed in the third quarter valued at $202,000. Oppenheimer & Co. Inc. grew its position in Chemed by 0.3% in the third quarter. Oppenheimer & Co. Inc. now owns 14,568 shares of the company’s stock valued at $7,358,000 after purchasing an additional 47 shares in the last quarter. Finally, Signaturefd LLC increased its stake in Chemed by 28.3% in the 3rd quarter. Signaturefd LLC now owns 367 shares of the company’s stock valued at $185,000 after buying an additional 81 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Tuesday, November 3rd. The stock was sold at an average price of $537.90, for a total transaction of $1,075,800.00. Following the completion of the transaction, the chief executive officer directly owned 82,220 shares in the company, valued at approximately $44,226,138. The trade was a 2.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Spencer S. Lee sold 920 shares of the business’s stock in a transaction that occurred on Monday, November 2nd. The stock was sold at an average price of $537.17, for a total value of $494,196.40. Following the transaction, the executive vice president directly owned 13,931 shares in the company, valued at $7,483,315.27. The trade was a 6.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 9,920 shares of company stock worth $5,223,056 in the last 90 days. Corporate insiders own 3.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Royal Bank Of Canada boosted their price target on shares of Chemed from $548.00 to $585.00 and gave the stock a “sector perform” rating in a research report on Thursday, October 29th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and upped their target price for the stock from $520.00 to $620.00 in a report on Wednesday, October 28th. Wall Street Zen raised Chemed from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 10th. Bank of America restated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Finally, Oppenheimer upped their price objective on Chemed from $590.00 to $625.00 and gave the stock an “outperform” rating in a research note on Thursday, October 29th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $603.00.

Chemed Stock Performance

Shares of CHE stock opened at $526.43 on Monday. The company has a fifty day moving average price of $514.46 and a two-hundred day moving average price of $465.08. Chemed Corporation has a one year low of $365.20 and a one year high of $562.24. The stock has a market cap of $6.85 billion, a P/E ratio of 25.19, a P/E/G ratio of 2.01 and a beta of 0.50. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.11 and a quick ratio of 1.08.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, October 27th. The company reported $6.75 earnings per share for the quarter, topping the consensus estimate of $6.44 by $0.31. The company had revenue of $690.94 million for the quarter, compared to analyst estimates of $685.04 million. Chemed had a net margin of 10.61% and a return on equity of 35.18%. Chemed’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same period in the previous year, the business earned $5.27 EPS. As a group, equities analysts predict that Chemed Corporation will post 24.05 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Monday, November 16th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. Chemed’s payout ratio is 13.40%.

Chemed Profile

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services.

VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.

Chemed’s businesses operate across the United States.